- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bodal Chemicals reported Q4 revenue of Rs. 453 Cr (+14% YoY) and FY25 Rs. 1,757 Cr (+24% YoY). Q4 EBITDA rose 62% QoQ to Rs. 50 Cr, with FY25 EBITDA at Rs. 171 Cr (+43% YoY). PAT stood at Rs. 14.5 Cr (Q4) and Rs. 18.5 Cr (FY25). Dye intermediates grew 36% to Rs. 667 Cr; dyestuff +6%, chlor-alkali +25%, basic chemicals +11%. Benzene derivatives began contributing at ~30% utilization, targeting 80%. Management expects FY26 revenue growth of ~10% to Rs. 1,900 Cr+, EBITDA margin of 11-12%, volume growth in dyestuffs (10-15%), and chlor-alkali debottleneck adding capacity. Focus remains on debt reduction and stable margins amid subsidiary pressures and price volatility.